FENC - FENNEC PHARMACEUTICALS INC.

QQQ $ 608.67 $ 0.46 (0.08 %)

DIA $ 471.98 $ -2.94 (-0.62 %)

SPY $ 671.87 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.88 $ -6.91 (-1.8 %)

Previous Close

$ 7.86

Open

$ 8.75

Bid

$ 7.93 x 6

Ask

$ 8.03 x 42

Day's Range

$ 7.75 - $ 8.45

52 Week Range

$ 3.96 - $ 9.92

Volume

911,773

Average Volume

Market Cap

221M

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-13-2025	09-30-2025	10-Q
2	08-14-2025	06-30-2025	10-Q
3	05-14-2025	03-31-2025	10-Q
4	03-26-2025	12-31-2024	10-K
5	11-08-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-14-2024	03-31-2024	10-Q
8	03-29-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-12-2023	03-31-2023	10-Q
12	03-29-2023	12-31-2022	10-K
13	11-14-2022	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-10-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q
20	03-30-2021	12-31-2020	10-K
21	11-16-2020	09-30-2020	10-Q
22	08-05-2020	06-30-2020	10-Q
23	05-14-2020	03-31-2020	10-Q
24	02-14-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-09-2019	06-30-2019	10-Q
27	05-10-2019	03-31-2019	10-Q
28	03-15-2019	12-31-2018	10-K
29	11-13-2018	09-30-2018	10-Q
30	08-13-2018	06-30-2018	10-Q
31	05-14-2018	03-31-2018	10-Q
32	03-28-2018	12-31-2017	10-K
33	11-13-2017	09-30-2017	10-Q
34	08-14-2017	06-30-2017	10-Q
35	05-12-2017	03-31-2017	10-Q
36	03-29-2017	12-31-2016	10-K
37	11-14-2016	09-30-2016	10-Q
38	08-12-2016	06-30-2016	10-Q
39	05-12-2016	03-31-2016	10-Q
40	03-28-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Earlier, Fennec Pharmaceuticals P...
11/14/2025 07:35:50

Fennec intends to use the net proceeds of the offering to repurchase and redeem certain indebtedness and the remaining net proc...

Fennec Pharmaceuticals Q3 EPS $(0.02), Inl...
11/13/2025 22:32:18

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. T...

Fennec Pharmaceuticals Plans To Launch Com...
11/13/2025 21:09:54

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) ("Fennec" or the "Company"), a specialty pharmaceutical com...

HC Wainwright & Co. Reiterates Buy on Fenn...
08/21/2025 14:36:20

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

Craig-Hallum Maintains Buy on Fennec Pharm...
08/15/2025 17:38:33

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

Fennec Pharmaceuticals Q2 EPS $(0.11) Miss...
08/14/2025 10:09:29

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate...

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

Fennec Pharmaceuticals Earnings Preview
08/13/2025 18:02:09

HC Wainwright & Co. Reiterates Buy on Fenn...
05/20/2025 10:54:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

Craig-Hallum Maintains Buy on Fennec Pharm...
05/14/2025 17:48:12

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

Fennec Pharmaceuticals Q1 EPS $(0.04) Beat...
05/13/2025 10:05:45

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate o...

Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

HC Wainwright & Co. Reiterates Buy on Fenn...
03/11/2025 10:52:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

nasdaq-sp-500-hit-6-month-lows-as-recession-fears-grow-whats-driving-markets-monday

Nasdaq, S&P 500 Hit 6-Month Lows As Recess...
03/10/2025 16:59:43

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...

Fennec Pharmaceuticals Q4 2024 GAAP EPS $(...
03/10/2025 10:06:22

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses ...

Earnings Scheduled For March 10, 2025
03/10/2025 08:32:14

why-bp-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket

Why BP Shares Are Trading Higher By 6%; He...
02/10/2025 11:08:13

Fennec Pharmaceuticals Announces Commercia...
02/07/2025 12:10:14

Fennec's PEDMARQSI Gains National Institut...
12/20/2024 11:19:34

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announced that Norgine Pharmaceut...

Fennec Pharmaceuticals Announced The Early...
12/19/2024 11:26:18

Pro forma for repayment, the convertible debt facility with Petrichor will be approximately $19 million and maintain a maturity...